Novel Agent First to Slow Disability in nrSPMS - Medscape
WEB1 day ago · September 20, 2024. 0. 0. COPENHAGEN, Denmark — A new investigational drug has become the first agent to slow disability in patients with nonrelapsing secondary progressive multiple sclerosis ...
Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
WEB6 days ago · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.
Key biomarkers identified for predicting disability progression in ...
WEB2 days ago · A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS). The breakthrough research has the potential to transform ...
Some people with MS may need earlier, higher-dose meds, study …
WEB3 days ago · Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure ...
A Cure for Multiple Sclerosis? Scientists Say Within Our Lifetime
WEBJun 12, 2024 · A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are keeping millions with MS healthier for longer – …
'Major moment in MS research' as new Octopus trial starts - BBC
WEBApr 4, 2023 · The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London,...
Could What Makes Multiple Sclerosis Worse Lead to a Cure?
WEBJun 28, 2023 · A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression that can rob patients of their mobility and independence over time.
CAR-T therapy for multiple sclerosis enters US trials for ... - Nature
WEBFeb 22, 2024 · The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers, raising hopes for a new therapeutic option for this devastating neurodegenerative disease...
FDA Approves First Biosimilar to Treat Multiple Sclerosis
WEBThe U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Early treatment could slow the onset of multiple sclerosis ... - NBC News
WEBApr 19, 2023 · Starting treatment for multiple sclerosis early — before symptoms even begin — could possibly delay the onset of the condition, new research finds.
Skip to content